Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(17 sites)
United States
Mayo Clinic Cancer Center- Phoenix, Phoenix, Arizona HonorHealth, Scottsdale, Arizona University of Colorado Health, Aurora, Colorado Yale Cancer Center, New Haven, Connecticut Ochsner Medical Center, New Orleans, Louisiana University of Michigan, Ann Arbor, Michigan Karmanos Cancer Institute, Detroit, Michigan Hackensack University Medical Center, Hackensack, New Jersey Memorial Sloan Kettering Cancer Center, New York, New York Sarah Cannon Research Institute - Oncology Partners, Nashville, Tennessee Vanderbilt-Ingram Cancer Center, Nashville, Tennessee NEXT Oncology- Austin, Austin, Texas NEXT Oncology- Dallas, Dallas, Texas MD Anderson, Houston, Texas NEXT Oncology San Antonio, San Antonio, Texas START Center for Care Center- San Antonio, San Antonio, Texas Baylor Scott and White Medical Center- Temple Clinic, Temple, Texas